Rchr
J-GLOBAL ID：202101013242584838
Update date: Jun. 21, 2024
Akatani Ritsu
アカタニ リツ | Akatani Ritsu
Affiliation and department：
Research field (1)：
Neurology
Research theme for competitive and other funds (1)：
- 2023 - 2026 免疫性神経疾患における病態保護的B細胞誘導療法の開発
Papers (6)：
-
Ritsu Akatani, Norio Chihara, Atsushi Hara, Asato Tsuji, Shusuke Koto, Kazuhiro Kobayashi, Tatsushi Toda, Riki Matsumoto. Interleukin-6 Signaling Blockade Induces Regulatory Plasmablasts in Neuromyelitis Optica Spectrum Disorder. Neurology(R) neuroimmunology & neuroinflammation. 2024. 11. 4. e200266
-
Ritsu Akatani, Norio Chihara, Shusuke Koto, Sotaro Mori, Takuji Kurimoto, Makoto Nakamura, Hisatsugu Tachibana, Yoshihisa Otsuka, Takehiro Ueda, Takashi Omori, et al. Efficacy and safety of mycophenolate mofetil for steroid reduction in neuromyelitis optica spectrum disorder: a prospective cohort study. Immunological medicine. 2024. 47. 2. 85-92
-
Shusuke Koto, Norio Chihara, Ritsu Akatani, Hiroko Nakano, Atsushi Hara, Kenji Sekiguchi, Riki Matsumoto, Tatsushi Toda. Transcription Factor c-Maf Promotes Immunoregulation of Programmed Cell Death 1-Expressed CD8+ T Cells in Multiple Sclerosis. Neurology(R) neuroimmunology & neuroinflammation. 2022. 9. 4
-
Atsushi Hara, Norio Chihara, Ritsu Akatani, Ryusei Nishigori, Asato Tsuji, Hajime Yoshimura, Michi Kawamoto, Yoshihisa Otsuka, Yasufumi Kageyama, Takayuki Kondo, et al. Circulating plasmablasts and follicular helper T-cell subsets are associated with antibody-positive autoimmune epilepsy. Frontiers in immunology. 2022. 13. 1048428-1048428
-
Ritsu Akatani, Norio Chihara, Hisatsugu Tachibana, Shusuke Koto, Hisatomo Kowa, Fumio Kanda, Riki Matsumoto, Tatsushi Toda. Validation of the Guy's Neurological Disability Scale as a screening tool for cognitive impairment in multiple sclerosis. Multiple sclerosis and related disorders. 2019. 35. 272-275
ｍore...
Return to Previous Page
